239 related articles for article (PubMed ID: 2421587)
1. Vasoactive intestinal peptide receptor antagonist [4Cl-D-Phe6, Leu17] VIP.
Pandol SJ; Dharmsathaphorn K; Schoeffield MS; Vale W; Rivier J
Am J Physiol; 1986 Apr; 250(4 Pt 1):G553-7. PubMed ID: 2421587
[TBL] [Abstract][Full Text] [Related]
2. Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages.
Pozo D; Montilla ML; Guerrero JM; Calvo JR
Eur J Pharmacol; 1997 Mar; 321(3):379-86. PubMed ID: 9085051
[TBL] [Abstract][Full Text] [Related]
3. Effect of [4Cl-D-Phe6,Leu17]VIP on the inhibition of pulsatile LH release by VIP and related peptides in the ovariectomized rat.
Weick RF; Stobie KM; Noh KA
Neuroendocrinology; 1992 Nov; 56(5):646-52. PubMed ID: 1488097
[TBL] [Abstract][Full Text] [Related]
4. Effects of intracoronary infusion of the vasoactive intestinal peptide antagonist [4Cl-D-Phe6-Leu17]VIP in the awake dog.
Quebbemann BB; Rivier J; Bache RJ
Peptides; 1991; 12(5):989-93. PubMed ID: 1800959
[TBL] [Abstract][Full Text] [Related]
5. Bicarbonate secretion in the guinea pig duodenum: functional characterization of peptide hormone receptors in duodenal enterocytes.
Reimer R; Odes HS; Beil W; Schwenk M; Muallem R; Sewing KF
Pharmacology; 1996 Jun; 52(6):339-46. PubMed ID: 8844783
[TBL] [Abstract][Full Text] [Related]
6. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
McArthur KE; Wood CL; O'Dorisio MS; Zhou ZC; Gardner JD; Jensen RT
Am J Physiol; 1987 Mar; 252(3 Pt 1):G404-12. PubMed ID: 2435170
[TBL] [Abstract][Full Text] [Related]
7. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
Zhou ZC; Gardner JD; Jensen RT
Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
[TBL] [Abstract][Full Text] [Related]
8. Action of natural glucagon on pancreatic acini: due to contamination by previously undescribed secretagogues.
Pandol SJ; Sutliff VE; Jones SW; Charlton CG; O'Donohue TL; Gardner JD; Jensen RT
Am J Physiol; 1983 Nov; 245(5 Pt 1):G703-10. PubMed ID: 6195929
[TBL] [Abstract][Full Text] [Related]
9. Modulation of human natural killer activity by vasoactive intestinal peptide (VIP) family. VIP, glucagon and GHRF specifically inhibit NK activity.
Sirianni MC; Annibale B; Tagliaferri F; Fais S; De Luca S; Pallone F; Delle Fave G; Aiuti F
Regul Pept; 1992 Mar; 38(1):79-87. PubMed ID: 1574603
[TBL] [Abstract][Full Text] [Related]
10. In vitro inhibitory effect of somatostatin on secretin action in exocrine pancreas of rats.
Matsushita K; Okabayashi Y; Hasegawa H; Koide M; Kido Y; Okutani T; Sugimoto Y; Kasuga M
Gastroenterology; 1993 Apr; 104(4):1146-52. PubMed ID: 7681794
[TBL] [Abstract][Full Text] [Related]
11. Stimulatory effects of Gila monster venom on rat pancreatic acini.
Dehaye JP; Winand J; Damien C; Poloczek P; Svoboda M; Christophe J
Peptides; 1984; 5(2):333-7. PubMed ID: 6206482
[TBL] [Abstract][Full Text] [Related]
12. Gastrin-releasing peptide directly releases pepsinogen from guinea pig chief cells.
Fiorucci S; McArthur KE
Am J Physiol; 1990 Nov; 259(5 Pt 1):G760-6. PubMed ID: 1700625
[TBL] [Abstract][Full Text] [Related]
13. The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide receptor: functional and binding studies on opossum internal anal sphincter smooth muscle.
Chakder S; Rattan S
J Pharmacol Exp Ther; 1993 Jul; 266(1):392-9. PubMed ID: 8392560
[TBL] [Abstract][Full Text] [Related]
14. Receptors for vasoactive intestinal peptide and secretin on small intestinal epithelial cells.
Binder HJ; Lemp GF; Gardner JD
Am J Physiol; 1980 Mar; 238(3):G190-6. PubMed ID: 6245588
[TBL] [Abstract][Full Text] [Related]
15. A cultured human renal epithelioid cell line responsive to vasoactive intestinal peptide.
Simmons NL
Exp Physiol; 1990 May; 75(3):309-19. PubMed ID: 2161676
[TBL] [Abstract][Full Text] [Related]
16. Effects of alcohols on the actions of VIP and secretin on acinar cells from guinea pig pancreas.
Uhlemann ER; Robberecht P; Gardner JD
Gastroenterology; 1979 May; 76(5 Pt 1):917-25. PubMed ID: 220130
[TBL] [Abstract][Full Text] [Related]
17. Actions of a newly isolated intestinal peptide PHI on pancreatic acini.
Jensen RT; Tatemoto K; Mutt V; Lemp GF; Gardner JD
Am J Physiol; 1981 Dec; 241(6):G498-502. PubMed ID: 6172986
[TBL] [Abstract][Full Text] [Related]
18. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist.
Waelbroeck M; Robberecht P; Coy DH; Camus JC; De Neef P; Christophe J
Endocrinology; 1985 Jun; 116(6):2643-9. PubMed ID: 2859987
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide receptor antagonists in rat seminal vesicle membranes.
RodrÃguez-Pena MS; Guijarro LG; Prieto JC
Eur J Pharmacol; 1991 Nov; 208(3):207-12. PubMed ID: 1663044
[TBL] [Abstract][Full Text] [Related]
20. Accelerated synthesis de novo of phosphatidylinositols in the rat exocrine pancreas is not necessarily associated with enzymatic hypersecretion. Secretin and vasoactive intestinal peptide (VIP) stimulate amylase output in vitro without favouring this synthesis [proceedings].
Calderon P; Furnelle J; Christophe J
Arch Int Physiol Biochim; 1977 Apr; 85(2):318-9. PubMed ID: 71091
[No Abstract] [Full Text] [Related]
[Next] [New Search]
